Intracoronary brachytherapy

Kuchulakanti B Wolfram R, "lorguson R, et al. Bivalirudin compared with llb/llla inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy. Cardiovasc Revasc Med 2005 6 154-159. [Pg.92]

TSable 1 Selected randomized clinical trials of intracoronary brachytherapy as adjunctive therapy during PCI... [Pg.281]

Abbreviations BMS, bare-metal stents ICB, intracoronary brachytherapy N/A, results not published NS, not statistically significant (P > 0.05) PCI, percutaneous coronary intervention FTCA, percutaneous transluminal coronary angioplasty POBA, plain old balloon angioplasty. [Pg.281]

Meerkin D, TardifJC, Bertrand Op et al. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections, J Am Coll Cardiol 2000 36( I ) 59—64. [Pg.287]

Costa MA, Sabate M, van der Giessen JM, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999 IOO(8) 789-792. [Pg.287]

Okada M, Tamai H, Kyo E, et al. Serial angioscopic findings after successful intracoronary brachytherapy for in-stent restenosis. Am J Cardiol 2006 97( I ) 21 —25. [Pg.287]

Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000 36(l) 65-8. [Pg.59]

Chu WW, Toguson R, Pichard AD, et al. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol 2005 17( 12) 659—662. [Pg.287]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...